<?xml version="1.0"?>
<Articles JournalTitle="Iranian Journal of Parasitology">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Parasitology</JournalTitle>
      <Issn>1735-7020</Issn>
      <Volume>15</Volume>
      <Issue>1</Issue>
      <PubDate PubStatus="epublish">
        <Year>2020</Year>
        <Month>03</Month>
        <Day>09</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Design, Construction and Immunogenicity Assessment of pEGFP-N1-KMP11-GP96 (Fusion) as a DNA Vaccine Candidate against Leishmania major Infection in BALB/c Mice</title>
    <FirstPage>11</FirstPage>
    <LastPage>21</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Abdolhossein</FirstName>
        <LastName>DALIMI</LastName>
        <affiliation locale="en_US">Department of Parasitology and Entomology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Vahid</FirstName>
        <LastName>NASIRI</LastName>
        <affiliation locale="en_US">Department of Parasitology, Razi Vaccine and Serum Research Institute, Agricultural Research, Education and Exten-sion Organization, Karaj, Iran</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2020</Year>
        <Month>03</Month>
        <Day>09</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Background: KMP-11 (Kinetoplastid membrane protein-&#x3A0;) exists in all species of kinetoplastid family. It is fully conserved and the protein produced by this gene can induce a very high cellular immune response. We aimed to design a suitable construction for a Leishmania major DNA vaccine and evaluate the protective efficacy of it as&#xA0;a candidate&#xA0;for DNA vaccine against&#xA0;cutaneous&#xA0;leishmaniasis in BALB/c mice.
Methods: This experimental study was conducted in Tehran City, Iran, between April 20, 2015 and May 30, 2016. KMP-11 gene of L. major (MRHO/IR/75/ER, Iranian strain) and NT-GP96 of Xenopus GP96 DNA from a pBluescript-GP96 plasmid were amplified by PCR and the purified PCR products were cloned into the pJET1.2/blunt plasmid vector, then, subcloned into pEGFP-N1 plasmid as an expression vector. Finally, the KMP-11 gene was fused with GP96 and afterward the combination cloned in pEGFP-N1. All the cloned genes confirmed by enzyme digestions. Then, four groups of mice were immunized with PBS, pEGFP-N1, pEGFP-N1-KMP, and pEGFP-N1-fusion. Four weeks after immunization, all animals were challenged with L. major virulent promastigotes.
Results: The constructed fusion&#xA0;potentially&#xA0;showed an ability to elicit Th1 responses that led to cutaneous lesion healing. Interestingly, the group received KMP11-GP96 &#x2013;GFP showed the highest ratio of IFN- &#x3B3; /IL-4 and IgG2a/IgG1 compare to other groups. No side effect was observed after using the fusion in the mice.
Conclusion: The constructed fusion could well stimulate both the cellular and humoral immune systems that led to cutaneous lesion healing in mice.</abstract>
    <web_url>https://ijpa.tums.ac.ir/index.php/ijpa/article/view/2828</web_url>
    <pdf_url>https://ijpa.tums.ac.ir/index.php/ijpa/article/download/2828/1007</pdf_url>
  </Article>
</Articles>
